Search for Clinical Trial Results

Sponsored By

Purpura, Thrombocytopenic - 50 Studies Found

Status Study
Recruiting Study Name: A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2013-06-06
Interventions:
  • Drug: Eltrombopag Tablets Eltr
Completed Study Name: Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2008-06-25
Interventions: Drug: Fostamatinib Disodium / R935788 R935788 tablets
Completed Study Name: Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2006-09-06
Interventions:
  • Drug: Rituximab 375mg/m2 per w
Completed Study Name: Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Date: 2007-01-17
Interventions: Drug: eltrombopag experimental
Completed Study Name: A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Date: 2010-03-25
Interventions: Drug: Eltrombopag olamine Thrombopoietin receptor agonist
Completed Study Name: A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2015-03-20
Interventions: Drug: Hetrombopag Olamine Hetrombopag Olamine 2.5mg, 5mg and 7.5mg
Completed Study Name: Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition:
  • Chronic Idiopathic Thrombocytopenic Purpura
  • Drug: Placebo Placebo Tablets

Terminated Study Name: Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2013-12-09
Interventions: Drug: BI 655064 subcutaneous injection
Completed Study Name: Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition:
  • Chronic Idiopathic Thrombocytopenic Purpura
  • Drug: SB-497115-GR 12.5mg SB-4
Completed Study Name: An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
Condition: